![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1732185
¼¼°èÀÇ ¾ç¼öõÀÚħ ½ÃÀå ±Ô¸ð : À¯Çüº°, ½Ã¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¹üÀ§ ¹× ¿¹ÃøGlobal Amniocentesis Needle Market Size By Type, By Procedure, By End-User, By Geographic Scope And Forecast |
¾ç¼öõÀÚħ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 1¾ï 8,143¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2026³âºÎÅÍ 2032³â±îÁö 2.7%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2032³â¿¡´Â 2¾ï 2,015¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¾ç¼öõÀÚħ ½ÃÀåÀÇ ½ÃÀå ÃËÁø¿äÀÎÀº ´Ù¾çÇÑ ¿äÀÎÀÇ ¿µÇâÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â ´ÙÀ½ÀÌ Æ÷ÇԵ˴ϴÙ:
»ê¸ð ¿¬·ÉÀÇ Áõ°¡ žÆÀÇ °Ç°, À¯ÀüÀÚ ÀÌ»ó, ±âŸ Àå¾Ö¸¦ Æò°¡ÇÏ´Â ¾ç¼ö õÀÚ¿Í °°Àº »êÀü Áø´Ü Ä¡·á´Â ¿©¼ºµéÀÌ ¿©·¯ °¡Áö ÀÌÀ¯·Î Ãâ»êÀ» ÁÖÀúÇϱ⠶§¹®¿¡ Á¡Á¡ ´õ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù.
À¯Àü¼º ÁúȯÀÇ À¯º´·ü ¾ç¼öõÀÚħ°ú °°Àº »êÀü Áø´Ü ±â¼úÀº ´Ù¿îÁõÈıº, ôÃßÀ̺ÐÁõ°ú °°Àº À¯Àü¼º ÁúȯÀ̳ª ¿°»öü ÀÌ»óÀ» Á¶±â¿¡ ¹ß°ßÇϰí Ä¡·áÇϱâ À§ÇØ ÇÊ¿äÇÕ´Ï´Ù.
±â¼ú °³¹ß : ¾ç¼öõÀÚħÀÇ ±â¼úÀÌ ¹ßÀüÇÏ¿© ´õ °¡´Ã°í, ´õ Á¤È®ÇÑ ¹Ù´Ã, ´õ ¿ì¼öÇÑ ¿µ»ó Áø´Ü¹ý, ´õ ³·Àº ¹®Á¦ ¹ß»ý À§Çè µîÀÌ ¸¸µé¾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¹ß·Î º¸´Ù ¾ÈÀüÇϰí Á¤È®ÇÑ °Ë»ç°¡ °¡´ÉÇØÁ® ½ÃÀå °³Ã´ÀÌ °¡¼Óȵǰí ÀÖ½À´Ï´Ù.
ÀÎ½Ä È®´ë : ÅÂ¾Æ ±âÇü ¹× ¼±Ãµ¼º ±âÇü ¿¹¹æ°ú Ä¡·á¿¡ ÀÖ¾î »êÀü °ËÁø ¹× Áø´ÜÀÇ ¿ªÇÒÀÌ ÀÓ»êºÎ ¹× ÀÇ·á Àü¹®°¡µé¿¡ ÀÇÇØ Á¡Á¡ ´õ ¸¹ÀÌ Àνĵǰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê¿Í ÀÇ·á Á¤Ã¥ : »êÀü °Ë»ç ºñ¿ëÀ» ³·Ãß°í, ƯÈ÷ °íÀ§Çè Àӽſ¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ôÀÓÀ¸·Î½á Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê, ÀÇ·á Á¤Ã¥, ȯ±Þ ÇÁ·Î±×·¥Àº ½ÃÀå È®´ë¸¦ Å©°Ô ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÀÇ·áºñ ÁöÃâ Áõ°¡ : ƯÈ÷ ½ÅÈï±¹¿¡¼ ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ´õ ¸¹Àº »ç¶÷µéÀÌ °í±Þ »êÀü °ü¸® ¹× ¾ç¼ö õÀÚ¿Í °°Àº Áø´Ü ½Ã¼úÀ» ¹ÞÀ» ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.
»ýȰ½À°üº´ÀÇ ¸¸¿¬ : ¾ç¼öõÀÚħ°ú °°Àº »êÀü Áø´Ü ±â¼úÀÇ Çʿ伺Àº »ê¸ðÀÇ ºñ¸¸, ´ç´¢º´, ¿À¿°¹°Áú ³ëÃâ µî žÆÀÇ °Ç°¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â »ýȰ½À°ü ¹× ȯ°æÀû ¿äÀΰú °ü·ÃµÈ Àå¾ÖÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
ÀÓ½ÅÀ² Áõ°¡ : ¾ç¼öõÀÚħ ½ÃÀåÀº Àα¸ Áõ°¡, ºÒÀÓ Ä¡·áÀÇ °³¼±, »çȸÀû ±âÁØÀÇ º¯È µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇÑ ÀϹÝÀûÀÎ ÀÓ½ÅÀ² Áõ°¡ÀÇ °á°ú·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.
±àÁ¤ÀûÀÎ ±ÔÁ¦ ȯ°æ : ¾ç¼ö õÀÚ ÀýÂ÷ ¹× °ü·Ã ±â¼úÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇÏ´Â ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú °¡À̵å¶óÀÎÀº °í°´ÀÇ ½Å·Ú¸¦ ³ôÀ̰í Á¦Ç° µµÀÔÀ» ¿ëÀÌÇϰÔÇÔÀ¸·Î½á ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÕ´Ï´Ù.
¾ç¼öõÀÚħ ¼¼°è ½ÃÀå ¾ïÁ¦¿äÀÎ
¸î °¡Áö ¿äÀÎÀÌ ¾ç¼öõÀÚħ ½ÃÀåÀÇ ¾ïÁ¦¿äÀÎ ¶Ç´Â µµÀüÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â ´ÙÀ½ÀÌ Æ÷ÇԵ˴ϴÙ:
±ÔÁ¦Àû Àå¾Ö¹° : ÀÇ·á±â±â ¹× ÀÇ·áÇàÀ§¿¡ Àû¿ëµÇ´Â ¾ö°ÝÇÑ ±ÔÁ¤Àº »ý»êÀÚ¿Í ÀÇ·áÁø¿¡°Ô ¾î·Á¿òÀ» ÃÊ·¡Çϰí, ÀÌ·Î ÀÎÇØ ½ÂÀÎ Áö¿¬°ú ³ôÀº ÄÄÇöóÀ̾𽺠ºñ¿ëÀ» ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÇÕº´Áõ À§Çè : À¯»êÀº Á¤±âÀûÀÎ Ä¡·áÀÓ¿¡µµ ºÒ±¸ÇÏ°í ¾ç¼ö õÀÚ¿¡ µû¸¥ À§Çè Áß ÇϳªÀÔ´Ï´Ù. °ü·Ã À§Çè¿¡ ´ëÇÑ ¿ì·Á·Î ÀÓ»êºÎ°¡ Ä¡·á¸¦ ¹ÞÁö ¾Ê´Â´Ù¸é ½ÃÀåÀÇ °¡´É¼ºÀº Á¦ÇÑÀûÀÏ ¼ö ÀÖ½À´Ï´Ù.
´ëü ½ºÅ©¸®´× ±â¼ú : ±âÁ¸ÀÇ ¾ç¼ö õÀÚ¸¦ ´ëüÇÒ ¼ö ÀÖ´Â ºñħ½ÀÀû »êÀü °Ë»ç(NIPT) ¹× ±âŸ ½ºÅ©¸®´× ±â¼úÀÌ °³¹ßµÇ¸é ¾ç¼öõÀÚħÀÇ Çʿ伺ÀÌ °¨¼ÒÇÒ ¼ö ÀÖ½À´Ï´Ù.
À±¸®Àû ¹× »çȸÀû °í·Á»çÇ× : ȯÀÚ¿Í ÀÇ·á Àü¹®°¡ÀÇ °áÁ¤Àº »êÀü °Ë»ç¿¡ ´ëÇÑ À±¸®Àû ¿ì·Á¿Í ƯÁ¤ À¯ÀüÀÚ ÀÌ»ó ¹ß°ß ½Ã ¹ß»ýÇÒ ¼ö ÀÖ´Â ¿µÇâ¿¡ ¿µÇâÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ´Â ¾ç¼ö õÀÚ ¼ö¼úÀÇ ¼ö¿ä¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.
ºñ¿ëÀÇ Á¦ÇÑ : ¾ç¼ö õÀÚ Ä¡·á´Â ƯÈ÷ º¸ÇèÀÌ ÃæºÐÇÏÁö ¾ÊÀº »ç¶÷µé¿¡°Ô´Â ºñ¿ëÀÌ ¸¹ÀÌ µé ¼ö ÀÖ½À´Ï´Ù. ƯÈ÷ ÀÇ·á ½Ã½ºÅÛÀÌ ¹ß´ÞÇÏÁö ¾ÊÀº Áö¿ªÀ̳ª »çȸ°æÁ¦Àû ÁöÀ§°¡ ³·Àº Áö¿ª¿¡¼´Â ºñ¿ë ¶§¹®¿¡ ÀÌ ¼ö¼ú¿¡ ´ëÇÑ Á¢±ÙÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù.
±â¼úÀû °úÁ¦ : ¾ç¼ö õÀÚ´Â Àß È®¸³µÈ ½Ã¼úÀÌÁö¸¸, ¾ÈÀü¼º°ú Á¤È®¼ºÀ» ³ôÀ̱â À§Çؼ´Â ¹Ù´ÃÀÇ µðÀÚÀΰú ¿µ»óÈ ±â¼úÀÇ Áö¼ÓÀûÀÎ °³¼±ÀÌ ÇÊ¿äÇÕ´Ï´Ù. ±×·¯³ª °í°¡ÀÇ ¿¬±¸°³¹ß ºñ¿ë°ú ±â¼úÀû Á¦¾àÀÌ ÀÌ·¯ÇÑ Áøº¸¸¦ °¡·Î¸·´Â Àå¾Ö¹°ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
ȯÀÚÀÇ ºÒ¾È°ú µÎ·Á¿ò : ½Ã¼úÀÇ ÅëÁõ°ú ºÒÆíÇÔ¿¡ ´ëÇÑ µÎ·Á¿ò, ¶Ç´Â ½Ã¼úÀÇ °¡´ÉÇÑ °á°ú¿¡ ´ëÇÑ °ÆÁ¤À¸·Î ÀÎÇØ ¾ç¼ö õÀÚ¸¦ ¹Þ´Â °ÍÀ» ÁÖÀúÇÏ´Â »ç¶÷µéÀÌ ÀÖÀ» ¼ö ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ö¿ä¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.
³·Àº Áö½Ä°ú ±³À° : ¾ç¼ö õÀÚ°¡ ÃæºÐÈ÷ Ȱ¿ëµÇÁö ¾Ê´Â ÀÌÀ¯´Â ȯÀÚ¿Í ÀÇ·á Àü¹®°¡µé »çÀÌ¿¡¼ ¾ç¼ö õÀÚÀÇ ÀåÁ¡, À§Ç輺, ÀûÀÀÁõ¿¡ ´ëÇÑ Áö½ÄÀÌ ºÎÁ·Çϱ⠶§¹®ÀÔ´Ï´Ù.
Amniocentesis Needle Market size was valued at USD 181.43 Million in 2024 and is projected to reach USD 220.15 Million by 2032, growing at a CAGR of 2.7% from 2026 to 2032.
The market drivers for the Amniocentesis Needle Market can be influenced by various factors. These may include:
Growing Maternal Age: Prenatal diagnostic treatments like amniocentesis, which evaluate foetal health, genetic abnormalities, and other disorders, are becoming more and more popular as women put off having children for a variety of reasons.
Prevalence of Genetic Disorders: Prenatal diagnostic techniques like amniocentesis are necessary for the early detection and treatment of genetic disorders and chromosomal abnormalities, such as Down syndrome, spina bifida, and others, due to their increasing incidence.
Technological Developments: Amniocentesis needle technology has advanced to produce thinner, more accurate needles, better imaging methods, and a lower risk of problems. These developments make the process safer and more accurate, which in turn accelerates market growth.
Expanding Awareness: Prenatal screening and diagnosis's role in preventing or treating foetal anomalies and birth defects is being increasingly recognised by pregnant parents and medical professionals, which supports the market's growth.
Government Initiatives and Healthcare Policies: By lowering the cost and increasing the accessibility of prenatal testing methods, particularly for high-risk pregnancies, government initiatives, healthcare policies, and reimbursement programmes can substantially propel market expansion.
Growing Healthcare Expenditure: More people can now obtain sophisticated prenatal care and diagnostic procedures, such as amniocentesis, thanks to rising healthcare spending, especially in emerging nations.
Prevalence of Lifestyle disorders: The need for prenatal diagnostic techniques like amniocentesis is fueled by the rising prevalence of disorders linked to a lifestyle and environmental factors that impact foetal health, such as mother obesity, diabetes, and exposure to pollutants.
Increase in Pregnancy Rates: The market for amniocentesis needles is growing as a result of the general increase in pregnancy rates, which is being driven by factors like population growth, improvements in fertility treatments, and shifting societal standards.
Positive Regulatory Environment: By boosting customer trust and easing product uptake, regulatory approvals and guidelines guaranteeing the safety and effectiveness of amniocentesis procedures and related technologies promote market growth.
Global Amniocentesis Needle Market Restraints
Several factors can act as restraints or challenges for the Amniocentesis Needle Market. These may include:
Regulatory Obstacles: Tight rules governing medical devices and practices can cause difficulties for producers and healthcare practitioners, resulting in approval delays or higher compliance costs.
Risk of Complications: Miscarriage is one of the hazards associated with amniocentesis, despite it being a regular treatment. The market potential may be limited if expecting mothers are discouraged from undergoing the treatment due to concerns about the associated hazards.
Alternative Screening Technologies: The necessity for amniocentesis needles may be decreased by the development of non-invasive prenatal testing (NIPT) and other screening technologies as alternatives to conventional amniocentesis.
Ethical and Social Considerations: Patients' and healthcare professionals' decisions may be influenced by ethical concerns about prenatal testing and the possible ramifications of detecting specific genetic abnormalities. This could have an effect on the demand for amniocentesis operations.
Cost Restrictions: Amniocentesis treatments can be costly, particularly for those without sufficient insurance. Access to these operations may be restricted due to cost, especially in areas with less developed healthcare systems or lower socioeconomic status.
Technological Challenges: Amniocentesis is a well-established procedure, but to increase safety and accuracy, continuous improvements in needle design and imaging technology would be needed. High research and development expenses or technological constraints, however, may prevent the creation of such advances.
Patient Anxiety and Fear: Some people may be discouraged from having amniocentesis due to fear of the procedure's pain or discomfort or worry about the procedure's possible outcomes, which could impact market demand.
Low Knowledge and Education: Underutilization of amniocentesis may be caused by low knowledge among patients and healthcare professionals on the advantages, dangers, and indications of the treatment, especially in areas with limited access to prenatal care or educational resources.
The Global Amniocentesis Needle Market is Segmented on the basis of Type, Procedure, End-User, and Geography.
Based on Type, the market is bifurcated into 100-150 mm Needles, Larger than 150 mm Needles, and Smaller Than 100 mm Needles. The 100-150 mm needles segment is expected to hold the largest market share. The factors can be attributed to the suitability of use for most patients and the widespread use of these needles on account of their optimal length.
Based on the Procedure, the market is bifurcated into Amniocentesis Procedures, Amnioinfusion Procedures, Amnioreduction Procedures, Cordocentesis Procedures, and Fetal Blood Transfusion Procedures. Amniocentesis Procedures are predicted to hold the most significant CAGR in the forecasted period due to the extensive use of this procedure to diagnose the abnormalities in the developing fetus and the high reliability of the amniocentesis technique.
Based on End-User, the market is bifurcated into Hospitals, Diagnostic Centers, Clinics, and Others. Hospitals are anticipated to hold the largest market share. The factors can be credited to the rising number of hospitals and better accessibility & availability of test results in hospitals.
Based on regional analysis, the Global Amniocentesis Needle Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share of the market will be dominated by North America owing to the growing healthcare expenditure and increasing government initiatives in this region.